Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bortezomib and pemetrexed disodium may stop the growth of tumor cells by blocking
some of the enzymes needed for cell growth. Giving bortezomib together with pemetrexed
disodium may kill more tumor cells.
PURPOSE: This phase I/II trial is studying the side effects and best dose of two different
schedules of bortezomib when given together with pemetrexed disodium and to see how well they
work in treating patients with advanced non-small cell lung cancer or other solid tumors.